InflaRx N.V. (IFRX)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $1.30
- As of
Kresmion compiles this page from IFRX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
InflaRx N.V. (IFRX): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-11-06.
See the full IFRX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for IFRX on one page. Preview it with sample data, then open it live with a free account.
Preview the IFRX dossierActive events for IFRX
- mediumEarnings above estimates
Q3-2026: Beat consensus by 68.6%, EPS $-0.0178 vs $-0.0568 estimate
- high13F: funds added
3 tracked funds increased IFRX this 2026Q2, institutional consensus
- high13F: large reduction
CITADEL ADVISORS LLC cut 80% of IFRX (2026Q2)
- high13F: large increase
CITADEL ADVISORS LLC added +123% to IFRX (2026Q2)
- medium13F: new position
MILLENNIUM MANAGEMENT LLC new position in IFRX
FREE, NO ACCOUNT
Every event on IFRX, as it fires
You are seeing 5 of 11 events recorded on IFRX since 2026-05-17.
The five above landed across 3 days. The other 6 were recorded on 4 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
IFRX positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| MILLENNIUM MANAGEMENT LLC FundCUSIP N44821101 · 2026Q2 | $1.3M | 0.00% |
| TWO SIGMA INVESTMENTS, LP FundCUSIP N44821101 · 2026Q2 | $406K | 0.00% |
| CITADEL ADVISORS LLC FundCUSIP N44821101 · 2026Q2 | $312K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, IFRX
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
Going concern statement
IFRX's 20-F filed Mar 20, 2026 states:
…which raises substantial doubt about its ability to continue as a going concern.
Read the 20-F on SEC EDGAR Every company with a going concern statement
More data on IFRX
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in IFRX on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on IFRX in the last 180 days.
Upstream: SEC EDGAR filings for IFRX
Kresmion, "InflaRx N.V. (IFRX) institutional holdings and SEC filings", data as of 2026-11-06, https://kresmion.com/research/IFRX. Upstream data: SEC EDGAR filings for IFRX.
Link to this data (HTML):
<a href="https://kresmion.com/research/IFRX">InflaRx N.V. (IFRX) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow IFRX on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to IFRX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.